Zentalis Pharmaceuticals
ZNTL
ZNTL
132 hedge funds and large institutions have $92.9M invested in Zentalis Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 50 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
52% less capital invested
Capital invested by funds: $195M → $92.9M (-$102M)
84% less call options, than puts
Call options by funds: $31K | Put options by funds: $188K
Holders
132
Holding in Top 10
2
Calls
$31K
Puts
$188K
Top Buyers
| 1 | +$3.36M | |
| 2 | +$2.55M | |
| 3 | +$2.38M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.45M |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$888K |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$5M | |
| 3 | -$3.35M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$3.18M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.74M |